Risk factors

Adial Pharmaceuticals (ADIL) risk factors

Item 1A of every Adial Pharmaceuticals, Inc. 10-K on file, and what changed from one year to the next.

  • FY2025 10-K risk factors

    63 risks, 4 new, 5 dropped, 8 reworded since the prior year. Adial Pharmaceuticals highlights new collaboration risks with Molteni for AD04, healthcare price-control regulations, and federal shutdown impacts.

    Filed Mar 05, 2026
  • FY2024 10-K risk factors

    64 risks. Clinical stage biotechnology company dependent on lead product candidate AD04 for treating alcohol use disorder.

    Filed Mar 04, 2025